Genenta Science SPA (GNTA) ADS

Sell:$1.33Buy:$1.40Price increased$0.02 (1.52%)

Prices delayed by at least 15 minutes
Sell:$1.33
Buy:$1.40
Change:Price increased$0.02 (1.52%)
Deal now
Prices delayed by at least 15 minutes
Sell:$1.33
Buy:$1.40
Change:Price increased$0.02 (1.52%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.

Key people

Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Richard B. Slansky
Chief Financial Officer
Barbara Regonini
Finance Director
Stefania Mazzoleni
Scientific Project Manager, Communication Officer
Carlo Russo
Chief Medical Officer, Head of Development
John Louis Cantello
Independent Director
Lauren Haeyong Chung
Independent Director
Armon Reza Sharei
Independent Director
Todd Wider
Independent Director
Click to see more

Key facts

  • Shares in issue
    18.29m
  • EPIC
    GNTA
  • ISIN
    US36870W1009
  • Location
    Italy
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $25.85m
  • Employees
    13
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.